EyePoint Pharmaceuticals
EYPT
EYPT
88 hedge funds and large institutions have $365M invested in EyePoint Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 33 increasing their positions, 14 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
40% more funds holding
Funds holding: 63 → 88 (+25)
11.13% more ownership
Funds ownership: 76.91% → 88.05% (+11%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
88
Holding in Top 10
1
Calls
$6.91M
Puts
$2.94M
Top Buyers
| 1 | +$21.7M | |
| 2 | +$14.2M | |
| 3 | +$11.7M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$9.98M |
| 5 |
Goldman Sachs
New York
|
+$7.14M |
Top Sellers
| 1 | -$2.88M | |
| 2 | -$2.81M | |
| 3 | -$2.48M | |
| 4 |
ACM
Altium Capital Management
New York
|
-$1.78M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$1.55M |